首页> 外文期刊>Advances in Therapy >Plasma homocysteine thiolactone associated with risk of macrovasculopathy in Chinese patients with type 2 diabetes mellitus
【24h】

Plasma homocysteine thiolactone associated with risk of macrovasculopathy in Chinese patients with type 2 diabetes mellitus

机译:中国2型糖尿病患者血浆同型半胱氨酸硫代内酯与大血管病变的风险相关

获取原文
获取原文并翻译 | 示例
       

摘要

This study investigated the role of homocysteine thiolactone (HcyT) in the development of macrovascular complications in Chinese patients with type 2 diabetes. HcyT has been proposed as a possible molecular basis for homocysteine (Hcy)-induced vascular damage.
机译:这项研究调查了高半胱氨酸硫代内酯(HcyT)在中国2型糖尿病患者大血管并发症发生中的作用。已经提出HcyT是高半胱氨酸(Hcy)诱导的血管损伤的可能分子基础。

著录项

  • 来源
    《Advances in Therapy》 |2008年第9期|914-924|共11页
  • 作者单位

    Department of Endocrinology Chinese PLA General Hospital Beijing China;

    Department of Endocrinology Chinese PLA General Hospital Beijing China;

    Department of Endocrinology Chinese PLA General Hospital Beijing China;

    Department of Endocrinology Chinese PLA General Hospital Beijing China;

    Department of Endocrinology Chinese PLA General Hospital Beijing China;

    Department of Endocrinology Chinese PLA General Hospital Beijing China;

    Department of Endocrinology Chinese PLA General Hospital Beijing China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    diabetes; homocysteine; homocysteine thiolactone; vasculopathy;

    机译:糖尿病;高半胱氨酸;高半胱氨酸硫代内酯;血管病;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号